martes, 24 de octubre de 2023

FDA Calls for More Data on Dupilumab for Chronic Spontaneous Urticaria, Manufacturers Announce Marcia Frellick

https://www.medscape.com/viewarticle/997633?src=

No hay comentarios:

Publicar un comentario